UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 156

Sortiert nach

Novel (89)Zr cell labeling approach for PET-based cell trafficking studies

EJNMMI research, 2015, Vol.5, p.19-19

2015

Volltextzugriff (PDF)

Nanostructured polyvinylpyrrolidone-curcumin conjugates allowed for kidney-targeted treatment of cisplatin induced acute kidney injury

Bioactive materials, 2023-01, Vol.19, p.282-291

2023

Volltextzugriff (PDF)

Cover Feature: Light‐Activated Protein Conjugation and 89Zr‐Radiolabelling with Water‐Soluble Desferrioxamine Derivatives (Chem. Eur. J. 32/2020)

Chemistry : a European journal, 2020-06, Vol.26 (32), p.7142-7142

2020

Volltextzugriff (PDF)

Zirconium immune-complexes for PET molecular imaging: Current status and prospects

Coordination chemistry reviews, 2023-03, Vol.479, p.215005, Article 215005

2023

Volltextzugriff (PDF)

Straightforward Synthesis of DFO ‐ An Octadentate Chelator for Zirconium‐89

ChemMedChem, 2024-02, Vol.19 (3), p.e202300495-n/a

2024

Volltextzugriff (PDF)

Radiolabelling and preclinical characterisation of [ 89 Zr]Zr-Df-ATG-101 bispecific to PD-L1/4-1BB

European journal of nuclear medicine and molecular imaging, 2024-05

2024

Volltextzugriff (PDF)

In Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate

Molecular therapy, 2019-01, Vol.27 (1), p.219-229

2019

Volltextzugriff (PDF)

Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression

Molecular pharmaceutics, 2018-01, Vol.15 (1), p.175-185

2018

Volltextzugriff (PDF)

89Zr for antibody labeling and in vivo studies – A comparison between liquid and solid target production

Nuclear medicine and biology, 2018-03, Vol.58, p.1-7

2018

Volltextzugriff (PDF)

Optimized anion exchange column isolation of zirconium-89 ( 89 Zr) from yttrium cyclotron target: Method development and implementation on an automated fluidic platform

Journal of Chromatography, 2018-04, Vol.1545 (C)

2018

Volltextzugriff (PDF)

Unraveling the in vivo fate of inhaled micro- and nanoplastics with PET imaging

The Science of the total environment, 2023-12, Vol.904, p.166320-166320, Article 166320

2023

Volltextzugriff (PDF)

Site-Specific Photoaffinity Bioconjugation for the Creation of <sup>89</sup>Zr-Labeled Radioimmunoconjugates

Molecular imaging and biology, 2023, Vol.25 (6), p.1104

2023

Volltextzugriff (PDF)

Recent Advances in Zirconium-89 Chelator Development

Molecules (Basel, Switzerland), 2018-03, Vol.23 (3), p.638

2018

Volltextzugriff (PDF)

On-cartridge preparation and evaluation of 68Ga-, 89Zr- and 64Cu-precursors for cell radiolabelling

Nuclear medicine and biology, 2019-04, Vol.71, p.23-31

2019

Volltextzugriff (PDF)

Synthesis and evaluation of bifunctional tetrahydroxamate chelators for labeling antibodies with 89Zr for imaging with positron emission tomography

Bioorganic & medicinal chemistry letters, 2018-03, Vol.28 (5), p.899-905

2018

Volltextzugriff (PDF)

Time of Flight Secondary Ion Mass Spectrometry imaging for precise localization of zirconium-labelled trastuzumab in xenograft cancer tumour tissues

Microchemical journal, 2022-10, Vol.181, p.107860, Article 107860

2022

Volltextzugriff (PDF)

Anion exchange and extraction chromatography tandem column isolation of zirconium-89 (89Zr) from cyclotron bombarded targets using an automated fluidic platform

Journal of Chromatography, 2022-07, Vol.1678

2022

Volltextzugriff (PDF)

Investigation of F and Zr Isotopes Self-Absorption and Dose Rate Parameters for PET Imaging

Dose-response, 2021-07, Vol.19

2021

Volltextzugriff (PDF)

Molecular imaging for non-invasive risk stratification of renal masses

Diagnostic and interventional imaging, 2024-07

2024

Volltextzugriff (PDF)

Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates

Bioorganic & medicinal chemistry, 2017-10, Vol.25 (20), p.5407-5414

2017

Volltextzugriff (PDF)

[ 89 Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [ 68 Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis

Cancer imaging, 2024-02, Vol.24 (1), p.27-27, Article 27

2024

Volltextzugriff (PDF)

Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2

Nuclear medicine and biology, 2023-07, Vol.122-123, p.108366, Article 108366

2023

Volltextzugriff (PDF)

Emerging chelators for nuclear imaging

Current opinion in chemical biology, 2021-08, Vol.63, p.152-162

2021

Volltextzugriff (PDF)

Tumor uptake and tumor/blood ratios for [89Zr]Zr-DFO-trastuzumab-DM1 on microPET/CT images in NOD/SCID mice with human breast cancer xenografts are directly correlated with HER2 expression and response to trastuzumab-DM1

Nuclear medicine and biology, 2018-12, Vol.67, p.43-51

2018

Volltextzugriff (PDF)

[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer

Molecular imaging and biology, 2016-12, Vol.18 (6), p.952-959

2016

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Englisch
(156)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Zirconium-89
(148)
Science & Technology
(108)
Life Sciences & Biomedicine
(90)
Positron Emission Tomography
(66)
Zirconium Isotopes
(47)
Radiology, Nuclear Medicine & Medical Imaging
(45)
Physical Sciences
(39)
Radioisotopes
(39)
Chemistry
(37)
Zirconium
(37)
Humans
(36)
Animals
(35)
Positron Emission
(35)
Tomography
(33)
Imaging
(32)
Tumors
(31)
Medicine
(28)
Monoclonal Antibodies
(28)
Nuclear Medicine
(28)
Oncology
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Novel (89)Zr cell labeling approach for PET-based cell trafficking studies

Nanostructured polyvinylpyrrolidone-curcumin conjugates allowed for kidney-targeted treatment of cisplatin induced acute kidney injury

Cover Feature: Light‐Activated Protein Conjugation and 89Zr‐Radiolabelling with Water‐Soluble Desferrioxamine Derivatives (Chem. Eur. J. 32/2020)

Zirconium immune-complexes for PET molecular imaging: Current status and prospects

Straightforward Synthesis of DFO ‐ An Octadentate Chelator for Zirconium‐89

Radiolabelling and preclinical characterisation of [ 89 Zr]Zr-Df-ATG-101 bispecific to PD-L1/4-1BB

In Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate

Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression

89Zr for antibody labeling and in vivo studies – A comparison between liquid and solid target production

Optimized anion exchange column isolation of zirconium-89 ( 89 Zr) from yttrium cyclotron target: Method development and implementation on an automated fluidic platform

Unraveling the in vivo fate of inhaled micro- and nanoplastics with PET imaging

Site-Specific Photoaffinity Bioconjugation for the Creation of <sup>89</sup>Zr-Labeled Radioimmunoconjugates

Recent Advances in Zirconium-89 Chelator Development

On-cartridge preparation and evaluation of 68Ga-, 89Zr- and 64Cu-precursors for cell radiolabelling

Synthesis and evaluation of bifunctional tetrahydroxamate chelators for labeling antibodies with 89Zr for imaging with positron emission tomography

Time of Flight Secondary Ion Mass Spectrometry imaging for precise localization of zirconium-labelled trastuzumab in xenograft cancer tumour tissues

Anion exchange and extraction chromatography tandem column isolation of zirconium-89 (89Zr) from cyclotron bombarded targets using an automated fluidic platform

Investigation of F and Zr Isotopes Self-Absorption and Dose Rate Parameters for PET Imaging

Molecular imaging for non-invasive risk stratification of renal masses

Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates

[ 89 Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [ 68 Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis

Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2

Emerging chelators for nuclear imaging

Tumor uptake and tumor/blood ratios for [89Zr]Zr-DFO-trastuzumab-DM1 on microPET/CT images in NOD/SCID mice with human breast cancer xenografts are directly correlated with HER2 expression and response to trastuzumab-DM1

[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer

Suchergebnisse filtern